Eli Lilly & Co. Stock Advances 4.9%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Eli Lilly & Co. rose 4.9% to $1,169.86 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.5% to 54,349.12 and the S&P 500 Index falling 0.2% to 7,723.55.

The stock's rise snapped a five-day losing streak.

Eli Lilly & Co. closed 6.4% below its 52-week high of $1,249.45, which the company achieved on July 7th.

The stock outperformed some of its peers, as Johnson & Johnson rose 1.0% to $257.59, Pfizer Inc. rose 1.6% to $25.81, and AbbVie Inc. rose 0.98% to $246.20.

Trading volume totaled 6.4 million, compared to the 50-day average of 3.0 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 05, 2026 16:35 ET (20:35 GMT)